Cover Image

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Saved in:

Bibliographic Details
Main Authors:	Liezel L. Griffin, MBBS (Author), Laura Cove-Smith, PhD (Author), Hana Alachkar, MD (Author), John A. Radford, MD (Author), Rebecca Brooke, MD (Author), Kim M. Linton, PhD (Author)
Format:	Book
Published:	Elsevier, 2018-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relapsing toxic epidermal necrolysis following COVID-19
by: Feben Messele, BS, et al.
Published: (2024)

Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib
by: Oscar M. Moreno-Arrones, MD, et al.
Published: (2018)

Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
by: Rachel Choi, MD, et al.
Published: (2022)

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020)

Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature
by: Bushra Khanjar, MD, et al.
Published: (2024)

Nivolumab-associated cutaneous T-cell lymphoma
by: Jennifer A. Marks, MD, et al.
Published: (2021)

Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcomeCapsule Summary
by: Paul Wasuwanich, BSc, et al.
Published: (2023)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
by: Margaux Dubus, MD, et al.
Published: (2023)

The multidisciplinary approach to the management toxic epidermal necrolysis syndrome (TENS) - a case report
by: E. D. Odai, et al.
Published: (2012)

Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: A population-based cohort study using the Shizuoka Kokuho databaseCapsule Summary
by: Nanako Ubukata, MS, et al.
Published: (2023)

Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: An underdiagnosed entity?
by: R. Matthew McLarney, MD, et al.
Published: (2018)

Physical and mental health impact of Stevens-Johnson syndrome/toxic epidermal necrolysis and post-hospital discharge care: Identifying practice gaps
by: Alexandra J. Coromilas, MD, et al.
Published: (2023)

Revisiting the "jelly-roll" technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
by: Samavia Khan, BS, et al.
Published: (2023)

Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab
by: Yuka Maya, MD, et al.
Published: (2020)

Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
by: Minorvi Amin, BS, et al.
Published: (2022)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
by: Connie Qiu, BS, et al.
Published: (2020)

Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure
by: Kristen Russomanno, MD, et al.
Published: (2021)

Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013)

Reply to: "Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure"
by: Leonardo Tjahjono, MD, et al.
Published: (2022)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms
by: Scott Stratman, MD, MPH, et al.
Published: (2024)

Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases
by: Angela Lu, BA, et al.
Published: (2021)

The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
by: William Andrew Isaac, et al.
Published: (2021)

Post Herpes Zoster dermatome/s - a therapeutic ground for cutaneous T-cell lymphoma (CTCL) & Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)
by: Ajith P. Kannangara
Published: (2015)

A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis
by: Andrea Francis, BS, et al.
Published: (2021)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
by: Joseph Han, BS, et al.
Published: (2022)

Causative drugs and clinical outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN overlap in children
by: Gomathy Sethuraman, et al.
Published: (2012)

From the Cochrane Library: Systemic Interventions for Steven-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS/TEN Overlap Syndrome
by: Gaurav Nitin Pathak, et al.
Published: (2024)

Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
by: Sophia Wix, MPhil, et al.
Published: (2023)

A case of pembrolizumab-induced toxic epidermal necrolysis with a delayed developmental timeline
by: William Driscoll, BS, et al.
Published: (2024)

Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult
by: Courtney M. Kenyon, BS, et al.
Published: (2024)

Fulvestrant-induced toxic epidermal necrolysis
by: Macarena Morales-Conde, et al.
Published: (2019)

Toxic epidermal necrolysis management with suprathel™
by: Miriam Miguel-Ferrero, et al.
Published: (2023)

A pediatric case of Stevens-Johnson syndrome/toxic epidermal necrolysis with rapid response to intravenous cyclosporine
by: Ali Alajmi, MD, et al.
Published: (2020)

Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
by: George D. Glinos, MD, et al.
Published: (2021)

Morphea-like subcutaneous panniculitis-like T-cell lymphoma
by: Keiko Tokuchi, MD, PhD, et al.
Published: (2024)

Vulvovaginal and ocular involvement and treatment in female patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: A review
by: M. Teresa Magone, MD, et al.
Published: (2021)

A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment
by: Tomoyo Oguri MD, PhD, et al.
Published: (2021)

A Case of Contact Toxic Epidermal Necrolysis
by: Weiwei Jiang, et al.
Published: (2024)

Toxic epidermal necrolysis induced by COVID-19
by: Duaa Alahmadi, et al.
Published: (2024)

Skin Detachment and Regrowth in Toxic Epidermal Necrolysis
by: Laurence Feldmeyer, et al.
Published: (2010)